Specifically, HLA silencing correlates with loss of global H3K27Me3 in MCC, both in fully developed tumors (208, 223), and during the transition of precursor squamous cells into MCC (173); this silencing can be reversed by EZH2 inhibition (223). The gene discussed is EZH2; the disease is Merkel cell skin cancer.